Smoore International Releases 2024 ESG Report with Innovations Update

Apr.14.2025
Smoore International Releases 2024 ESG Report with Innovations Update
Smoore International releases 2024 ESG report, showcasing R&D investment and technological innovations in the electronic vaping industry.

Recently, Smoore International Holdings Limited (06969.HK, "Smoore International") released its "2024 Environmental, Social and Governance Report". The report contains information on the company's annual progress in product and technology innovation. Data from the report shows that Smoore invested approximately 1.57 billion RMB in research and development in 2024, with 1609 R&D personnel. The company has established a research and development system including research institutes, technology centers, product development teams, and technology industrialization centers.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance Report

 

The report by Firsts found new developments in the field of electronic atomization technology in the year 2024.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG Report Content | Image Source: 2024 Environmental, Social, and Governance Report.

 

FEELM technology platform: POWER ALPHA 2.0 version supports over 15,000 puffs, with a battery energy density reportedly increased by 40% and a 70% reduction in self-discharge rate. 

The FEELM Turbo ceramic core solution is said to increase flavor intensity by 200%, vapor production by 80%, and puff count by over 30%. 

FEELM Pro brings two different series of high puff count solutions: the TPD compliant 5000 puff solution TANKER and the TPD compliant 3200 puff four-in-one solution QUAD SHOT Pro.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance Report

 

VAPORESSO, a self-owned brand, has launched the XROS, LUXE, ECO, and ARMOUR series products. The company has also introduced the VIBE product platform, with a focus on providing a similar taste and ease of use as disposable products, along with stylish design. 

 

The taste emphasizes delicacy, richness, and consistency; ease of use emphasizes large capacity, adjustability, easy pod replacement, and strong battery life; the design style aims for a young and trendy look, incorporating integrated design and screen display technology. 

 

The report notes that VAPORESSO products have won several awards, including the MUSE Design Award, London Design Award, IDA International Design Award, French Bilateral Design Award, German Design Award, and International CMF Design Award.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance report

 

In other areas of atomization applications, the report disclosed the following information:

 

HNB (Heated Tobacco Product)/Hybrid/e-cigarette product: The MiEE product combines heating tobacco and vaporization functions, using plant extract technology that is compatible with over 80% of heating sticks. The report states that this product reduces harmful organic compounds by 1.97 times compared to other HTP products, improves performance by 30%, and increases nicotine delivery by 50%.

 

Moyal launched its MOYAL Rain brand in 2024, featuring TPS transdermal technology to aerosolize high-viscosity essence for skin penetration. The product line includes both consumer and professional-grade devices (2B+2C). 

 

In the field of aerosolized medicine, its subsidiary Transpire Bio completed the introduction of inhalation devices for asthma and COPD, with key indicators meeting European and American regulatory requirements. Collaborations with international pharmaceutical companies have been established to advance the development of integrated medications with inhalation delivery devices (2B+2C). 

 

The report also highlights an iF Design Award-winning cartridge-based product, utilizing 100% tobacco extract and incorporating a rotating pop-up hygienic mouthpiece.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
The League of Municipalities of the Philippines (LMP) has urged President Ferdinand Marcos Jr. to prioritize the Smoke- and Vape-Free Bill, seeking a nationwide legal framework for tobacco and vape regulation. Local government leaders said national legislation would help standardize enforcement and strengthen public health measures. The proposal remains at the advocacy stage and has not yet become law.
Jul.29
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31